Esperion Offers Results Of Five Studies Of Heart DrugPlymouth-based Esperion Therapeutics Monday announced the results from a Phase 1 study and four preclinical studies for its heart disease drug candidate ETC-1002. Initial results look promising.
Esperion Starts Phase 2 Trial Of Cholesterol Buster

More From CBS Detroit

Best Cooking Classes In DetroitLearn how to whip up some wonderful dishes while having fun!
5 Bucket List Items To Cross Off In DetroitThe “must-do” items for anyone making a trip to Detroit.
Best Spots For A Quick Lunch In Downtown DetroitThese places will get you in and out.

Watch & Listen LIVE